Research and Innovation

On behalf of the U.S. Department of State’s Chemical Security Program (CSP), CRDF Global is pleased to offer grants to improve the physical and procedural security of chemical laboratories and facilities. These Chemical Security Improvement Grants (CSIG) contribute to the security of industrial and academic chemical facilities, including their employees and their communities, and aim to prevent the accidental or intentional misuse of chemicals. CSIGs are one-time awards ranging from $2,000 to $30,000 in value with applications accepted on a quarterly basis.

Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) solicits R01 research projects that seek to investigate actionable synthetic vulnerabilities that can be conditionally paired with tumor responses to radiation therapy. The goal of the Precision Approaches in Radiation Synthetic Combinations (PAIRS) program is to develop radiation-synthetic combination strategies and facilitate their adoption into the precision medicine toolkit toward building new and effective anticancer treatments.

Funder: National Institute of Health

Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) intends to facilitate well planned clinical trials across the cancer prevention and control spectrum aimed at improving prevention/ interception, cancer-related health behaviors, screening, early detection, healthcare delivery, management of treatment-related symptoms, supportive care, and the long-term outcomes of cancer survivors.

Implementation-focused projects that prove the viability of, or pilot, solutions in commercial value chains, that address problematic practices in this sector, including but not limited to excessive consumption of raw materials, water, and energy; and generation and poor management of liquid effluents and solid waste. Projects should bring together the following parties:

The Leakey Foundation exclusively funds research related to human origins. Priority of funding is commonly given to exploratory phases of promising new research projects that meet the stated purpose of the Foundation. The majority of The Leakey Foundation’s Research Grants awarded to doctoral students are in the $3,000-$15,000 range with a funding limit of $20,000. Larger grants given to senior scientists and post-doctoral researchers may be funded up to $30,000.

The purpose of this Funding Opportunity Announcement (FOA) is to encourage research grant applications on the development and testing of behavioral and integrative treatments for drug and alcohol use, abuse, and dependence. This FOA reaffirms the continued commitment of NIDA to major programs of research on behavioral and integrative treatments. The term "behavioral treatments" is used here in a broad sense and includes but is not limited to psychotherapies, cognitive, relapse prevention, remediative, rehabilitative, skills training, counseling, family, and exercise therapies.

The goal of this funding opportunity announcement is to support meritorious research projects that involve secondary data analyses of existing oral or craniofacial database resources, or that develop needed statistical methodology for analyzing existing dental, oral or craniofacial databases.

Funder: National Institute of Health

URL: https://grants.nih.gov/grants/guide/pa-files/PAR-22-160.html

Deadline: October 16, 2023, February 16, 2023

The purpose of this Funding Opportunity Announcement (FOA) is to invite exploratory/developmental research grant applications (R21) for innovative informatics methods and algorithms to improve the acquisition, analysis, visualization, or interpretation of data across the cancer research continuum including cancer biology, cancer treatment and diagnosis, early cancer detection, risk assessment and prevention, cancer control and epidemiology, and/or cancer health disparities.

Development Innovation Ventures (DIV) provides grant funding to innovators and researchers to test new ideas, take strategic risks, build evidence of what works, and advance the best solutions.

DIV’s tiered-funding model embraces risk at early stages and mitigates risk at later stages, ensuring that funding is targeted to the most cost-effective innovations that can improve people’s lives.DIV takes a broad approach to innovation; innovations can be business models, products, behavioral interventions, applied research, or replications of proven innovations in novel environments. 

The goal of this funding opportunity announcement (FOA) is to advance research to discover and validate novel biomarkers of TB infection and subsequent risk of progression to TB disease in young children with and without HIV.

Funder: National Institutes of Health

URL: https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-22-015.html